Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial.
暂无分享,去创建一个
Sebastiaan Overeem | S. Overeem | M. Verbeek | J. Claassen | M. Rikkert | S. Ooms | Sharon Ooms | Jurgen A H R Claassen | Marcel Olde Rikkert | Kees Besse | Marcel Verbeek | K. Besse | Kees Besse
[1] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[2] William J. Jagust,et al. Lifespan brain activity, β-amyloid, and Alzheimer's disease , 2011, Trends in Cognitive Sciences.
[3] G. Borm,et al. Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers , 2012, Neurobiology of Aging.
[4] David M Holtzman,et al. Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo , 2006, Nature Medicine.
[5] D. Dinges,et al. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. , 2003, Sleep.
[6] D. Holtzman,et al. Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.
[7] C. Masters,et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.
[8] Martin Hallbeck,et al. Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance , 2014, Neurobiology of Disease.
[9] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[10] Giorgio F. Gilestro,et al. Widespread Changes in Synaptic Markers as a Function of Sleep and Wakefulness in Drosophila , 2009, Science.
[11] Chengjie Xiong,et al. Sleep quality and preclinical Alzheimer disease. , 2013, JAMA neurology.
[12] G. Tononi,et al. Cortical Firing and Sleep Homeostasis , 2009, Neuron.
[13] D. Bennett,et al. Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons. , 2013, Sleep.
[14] D. Bennett,et al. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. , 2013, JAMA neurology.
[15] David M Holtzman,et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.
[16] Daniel J. R. Christensen,et al. Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.
[17] M. D. de Leon,et al. GREATER RISK OF ALZHEIMER'S DISEASE IN OLDER ADULTS WITH INSOMNIA , 2011, Journal of the American Geriatrics Society.
[18] S. Overeem,et al. Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: Focus on the role of hypocretin and melatonin , 2013, Ageing Research Reviews.
[19] Yo-El Ju,et al. Effects of Age and Amyloid Deposition on A Dynamics in the Human Central Nervous System , 2022 .
[20] R. Malinow,et al. APP Processing and Synaptic Function , 2003, Neuron.
[21] David L. Brody,et al. Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain , 2008, Science.
[22] Steven Mennerick,et al. Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.
[23] D. Holtzman,et al. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. , 2001, Journal of Alzheimer's disease : JAD.
[24] D. Holtzman,et al. Amyloid-beta dynamics in the injured human brain , 2009, Alzheimer's & Dementia.
[25] Susan M Resnick,et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. , 2013, JAMA neurology.
[26] D. Llano,et al. Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels , 2012, Alzheimer's & Dementia.
[27] A. Chesson,et al. The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications , 2007 .
[28] Christina A. Wilson,et al. Presenilins are not required for Aβ42 production in the early secretory pathway , 2002, Nature Neuroscience.
[29] Seiji Nishino,et al. Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle , 2009, Science.
[30] D. Perani,et al. FLUCTUATIONS OF CSF AMYLOID-β LEVELS: IMPLICATIONS FOR A DIAGNOSTIC AND THERAPEUTIC BIOMARKER , 2007, Neurology.